GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (TSX:DHT.UN) » Definitions » ROE %

DRI Healthcare Trust (TSX:DHT.UN) ROE % : -4.47% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is DRI Healthcare Trust ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. DRI Healthcare Trust's annualized net income for the quarter that ended in Mar. 2024 was C$-33.6 Mil. DRI Healthcare Trust's average Total Stockholders Equity over the quarter that ended in Mar. 2024 was C$750.0 Mil. Therefore, DRI Healthcare Trust's annualized ROE % for the quarter that ended in Mar. 2024 was -4.47%.

The historical rank and industry rank for DRI Healthcare Trust's ROE % or its related term are showing as below:

TSX:DHT.UN' s ROE % Range Over the Past 10 Years
Min: 3.09   Med: 5.69   Max: 19.77
Current: 17.71

During the past 3 years, DRI Healthcare Trust's highest ROE % was 19.77%. The lowest was 3.09%. And the median was 5.69%.

TSX:DHT.UN's ROE % is ranked better than
86.69% of 999 companies
in the Drug Manufacturers industry
Industry Median: 4.15 vs TSX:DHT.UN: 17.71

DRI Healthcare Trust ROE % Historical Data

The historical data trend for DRI Healthcare Trust's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust ROE % Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23
ROE %
5.69 3.18 19.67

DRI Healthcare Trust Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.22 74.98 -3.11 15.75 -4.47

Competitive Comparison of DRI Healthcare Trust's ROE %

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DRI Healthcare Trust's ROE % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's ROE % distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's ROE % falls into.



DRI Healthcare Trust ROE % Calculation

DRI Healthcare Trust's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=123.835/( (505.825+753.304)/ 2 )
=123.835/629.5645
=19.67 %

DRI Healthcare Trust's annualized ROE % for the quarter that ended in Mar. 2024 is calculated as

ROE %=Net Income (Q: Mar. 2024 )/( (Total Stockholders Equity (Q: Dec. 2023 )+Total Stockholders Equity (Q: Mar. 2024 ))/ count )
=-33.552/( (753.304+746.791)/ 2 )
=-33.552/750.0475
=-4.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2024) net income data. ROE % is displayed in the 30-year financial page.


DRI Healthcare Trust  (TSX:DHT.UN) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-33.552/750.0475
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-33.552 / 135.652)*(135.652 / 1171.5435)*(1171.5435 / 750.0475)
=Net Margin %*Asset Turnover*Equity Multiplier
=-24.73 %*0.1158*1.562
=ROA %*Equity Multiplier
=-2.86 %*1.562
=-4.47 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2024 )
=Net Income/Total Stockholders Equity
=-33.552/750.0475
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-33.552 / -33.552) * (-33.552 / 135.652) * (135.652 / 1171.5435) * (1171.5435 / 750.0475)
= Tax Burden * Pretax Margin % * Asset Turnover * Equity Multiplier
= 1 * -24.73 % * 0.1158 * 1.562
=-4.47 %

Note: The net income data used here is four times the quarterly (Mar. 2024) net income data. The Revenue data used here is four times the quarterly (Mar. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


DRI Healthcare Trust ROE % Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


DRI Healthcare Trust (TSX:DHT.UN) Business Description

Traded in Other Exchanges
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
DRI Healthcare Trust is a pioneer in global pharmaceutical royalty monetization with a more than 30-year history of accelerating innovation by providing capital to inventors, academic institutions, and biopharma companies. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world.

DRI Healthcare Trust (TSX:DHT.UN) Headlines

No Headlines